ReproNovo has two drug candidates in clinical Phase 2 addressing three disease conditions.
Founders
Jean Marie Duvall, Dr. Joan-Carles Arce, BingMei Hao
Company Description
ReproNovo is a startup specializing in reproductive medicine and women's health, developing novel therapies for under-addressed indications including male and female infertility and uterine diseases.
Market
Women's Health
Location
Lausanne,
Switzerland
Coinvestors
Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, ALSA Ventures